Development and validation of participation and positive psychologic function measures for stroke survivors.
OBJECTIVE
To evaluate the reliability and validity of Neurologic Quality of Life (NeuroQOL) item banks that assess quality-of-life (QOL) domains not typically included in poststroke measures.


METHODS
Secondary analysis of item responses to selected NeuroQOL domains.


METHODS
Community.


METHODS
Community-dwelling stroke survivors (n=111) who were at least 12 months poststroke.


METHODS
Not applicable.


METHODS
Five measures developed for 3 NeuroQoL domains: ability to participate in social activities, satisfaction with participation in social activities, and positive psychologic function.


RESULTS
A single bank was developed for the positive psychologic function domain, but 2 banks each were developed for the ability-to-participate and satisfaction-with-participation domains. The resulting item banks showed good psychometric properties and external construct validity with correlations with the legacy instruments, ranging from .53 to .71. Using these measures, stroke survivors in this sample reported an overall high level of QOL.


CONCLUSIONS
The NeuroQoL-derived measures are promising and valid methods for assessing aspects of QOL not typically measured in this population.
Bode
Rita K
RK
Department of Physical Medicine and Rehabilitation, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. r-bode@comcast.net
Heinemann
Allen W
AW
Butt
Zeeshan
Z
Stallings
Jena
J
Taylor
Caitlin
C
Rowe
Morgan
M
Roth
Elliot J
EJ
D000368:Aged; D002641:Chicago; D005260:Female; D006801:Humans; D007406:Interview, Psychological; D008297:Male; D009483:Neuropsychological Tests; D011594:Psychometrics; D011788:Quality of Life; D015203:Reproducibility of Results; D012917:Social Adjustment; D020521:Stroke / Q000523:psychology*; D000071939:Stroke Rehabilitation; D017741:Survivors / Q000523:psychology; D016896:Treatment Outcome
Qual Life Res. 1996 Apr;5(2):265-74
8998495
Clin Rehabil. 2003 Aug;17(5):548-52
12952162
J Rehabil Med. 2008 Jul;40(7):518-23
18758667
Stroke. 1993 Aug;24(8):1173-7
8342192
Curr Opin Neurol. 2005 Dec;18(6):681-91
16280680
Am J Phys Med Rehabil. 2002 Sep;81(9):639-44
12172514
Int J Rehabil Res. 2007 Dec;30(4):339-42
17975455
Lancet Oncol. 2006 Nov;7(11):883-4
17081911
Top Stroke Rehabil. 1994 Sep;1(3):1-15
27680951
Lancet. 2004 Jun 12;363(9425):1925-33
15194251
Med Care. 2000 Sep;38(9 Suppl):II66-72
10982091
Stroke. 2009 Jun;40(6):e431-40
19390074
Disabil Rehabil. 2007 Apr 15;29(7):559-66
17453976
Health Qual Life Outcomes. 2008 Jul 02;6:47
18597691
Top Stroke Rehabil. 2003 Winter;9(4):82-91
14523702
Arch Phys Med Rehabil. 1996 Dec;77(12):1226-32
8976303
Value Health. 2006 Nov-Dec;9(6):394-401
17076870
Am Psychol. 2006 Jan;61(1):50-5; discussion 62-71
16435976
Med Care. 2000 Sep;38(9 Suppl):II28-42
10982088
J Epidemiol Community Health. 1995 Oct;49(5):513-7
7499995
Disabil Rehabil. 2004 Mar 18;26(6):346-52
15204486
Qual Life Res. 1999 May;8(3):245-53
10472155
Med Care. 1992 Jun;30(6):473-83
1593914